TRPV1 and arthropathy: A number of studies have indicated that the TRPV1, which seems to mediate the calcium dependent proliferative and secretory responses of the synoviocytes in the event of joint inflammation, might be a possible and valuable target for treating joint diseases (46, 87), even in the horse (4).